This is an effort where industry and academia need to closely collaborate to find the right patient cohorts, which is not an easy task in rare disease. Meanwhile, he wants clinicians to know that tirzepatide is a good option for treating obesity, hyperphagia, MASLD, and type 2 diabetes in AS, but because of the rapid therapeutic response it produces, patients require careful monitoring
(5.4) Long-Term Suppression of Growth in Pediatric Patients: Closely monitor growth (height and weight) in pediatric patients
We'll assess the product, get your reconstitution and dose right, and put you on a proper protocol instead of guesswork
The speed of regain depends on three key factors: how long you took the medication, your starting weight, and whether you maintained the dietary and exercise habits you developed during treatment
15 mg-2 group: 35.7%